Literature DB >> 27531253

The 100 classic papers in ulcerative colitis: a bibliometric analysis.

Tara M Connelly1, Liam Devane1, John C Kelly2, Paula Wrafter2, Evangelos Messaris3.   

Abstract

BACKGROUND: The identification of the top 100 papers in ulcerative colitis (UC) using citation analysis provides a unique insight into the advancement of disease understanding and subsequent treatment innovations that have progressed over time.
METHODS: The Thomson Reuters Web of Knowledge was used to identify the 100 most cited UC manuscripts. Title, first and senior authors, institution and department of first author, journal, country of origin, year and topic of each manuscript were analyzed.
RESULTS: The top 100 manuscripts were published between 1955-2012. Thirty eight percent of the manuscripts originated from the US followed by the UK (26%). Genetics was the topic with the most publications (n = 27), followed by treatment (n = 22) and immunological pathways (n = 17). Truelove had the highest amount of authorships. The institutions with the highest number of publications were St. Mark's, London and the Radcliffe Infirmary.
CONCLUSION: This list of highly cited papers identifies the topics and authors that have made the most impact in the study of UC over the last century. This paper provides a reference of what could be considered as the most influential UC papers and serves as a reference of what comprises a 'highly citable' manuscript for both researchers and clinicians.

Entities:  

Keywords:  IBD; Ulcerative colitis; bibliometric analysis; colorectal cancer; inflammatory bowel disease

Year:  2016        PMID: 27531253     DOI: 10.1080/17474124.2016.1216786

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  8 in total

Review 1.  The 100 Most-Cited Articles in the Field of Colorectal Diseases from 1955 to 2020: A Bibliometric Analysis.

Authors:  Chunmei Zhang; Mengqi Luo; Hanlong Zhu; Jian Zhou; Lin Miao
Journal:  Turk J Gastroenterol       Date:  2022-03       Impact factor: 1.555

2.  The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.

Authors:  Keeley L Rose; Philip M Sherman; Jane Cooke-Lauder; Mina Mawani; Eric I Benchimol; Gilaad G Kaplan; Charles N Bernstein; Alain Bitton; Sanjay K Murthy; Geoffrey C Nguyen; Kate Lee
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

3.  Biologic therapy for Crohn's disease over the last 3 decades.

Authors:  Ji-Liang Shen; Zheng Zhou; Jia-Sheng Cao; Bin Zhang; Jia-Hao Hu; Jia-Ying Li; Xiao-Ming Liu; Sarun Juengpanich; Ming-Song Li; Xu Feng
Journal:  World J Clin Cases       Date:  2022-01-14       Impact factor: 1.337

4.  Characteristics and Trends of Highly Cited Articles in Calcaneus Fracture Research.

Authors:  Cody J Goedderz; Colin K Cantrell; Stephen D Bigach; Muhammad Y Mutawakkil; Erik B Gerlach; Bennet A Butler; Anish R Kadakia
Journal:  Foot Ankle Orthop       Date:  2022-03-28

5.  Highly Cited Articles in Periacetabular Osteotomy Research.

Authors:  Colin K Cantrell; Cody J Goedderz; Ryan S Selley; Ernest L Sink; Michael D Stover
Journal:  Hip Pelvis       Date:  2022-06-07

6.  Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021.

Authors:  Chuan Liu; Rong Yu; Jixiang Zhang; Shuchun Wei; Fumin Xue; Yingyun Guo; Pengzhan He; Lining Shang; Weiguo Dong
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

Review 7.  Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021.

Authors:  Tai Zhang; Beihua Zhang; Wende Tian; Fengyun Wang; Jiaqi Zhang; Xiangxue Ma; Yuchen Wei; Xudong Tang
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

8.  What can we learn from top-cited articles in inflammatory bowel disease? A bibliometric analysis and assessment of the level of evidence.

Authors:  Samy A Azer; Sarah Azer
Journal:  BMJ Open       Date:  2018-07-12       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.